针刺辅助治疗脑卒中后认知障碍的疗效与安全性评价:随机对照试验方案
本方案拟将脑卒中后认知障碍患者随机分为针刺联合口服药物组与西医治疗对照组,所有参与者继续接受常规药物治疗。主要结局为第12周简易精神状态检查量表(MMSE)评分,由两名培训合格的评价者联合检查并取平均分,治疗前3天及治疗后4周各测一次。该试验可能为针刺治疗PSCI的临床有效性、安全性和成本效果提供证据。
要点
- 针刺联合口服药物与单纯西医治疗对照,评价PSCI辅助治疗效果。
- 主要结局为第12周MMSE评分,由两名评价者独立评分取均值。
- 所有参与者均继续接受常规药物治疗,试验注册号ChiCTR2000029926。
核心结论
- 该随机对照试验方案旨在评价针刺辅助治疗脑卒中后认知障碍的临床有效性、安全性和成本效果。
研究设计与样本
- 研究将PSCI患者随机分为两组:干预组为针刺联合口服药物,对照组为西医治疗方案。
- 所有参与者继续接受常规药物治疗,主要结局在第12周采用MMSE量表评估。
- MMSE由两名培训合格的评价者联合检查并独立评分,取两者平均值为最终得分。
- MMSE测试时间点为治疗前3天及治疗后4周各一次。
关键数值与推荐
- 主要结局指标为第12周MMSE量表评分。
- MMSE由两名评价者独立评分,取平均分作为最终得分。
- MMSE测试于治疗前3天和治疗后4周各进行一次。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Post-stroke cognitive impairment (PSCI) is a series of syndromes that meet the diagnostic criteria for cognitive impairment that appear after a stroke. The treatment of PSCI with oral drugs alone is not ideal and has obvious side effects. Therefore, complementary and alternative treatments are needed for patients with insufficient or significant side effects of oral medications. Therefore, we will evaluate the clinical effectiveness and safety of acupuncture in the treatment of PSCI. METHODS/DESIGN: In this study, patients will be randomly divided into two groups. Intervention group: acupuncture combined with oral medication. CONTROL GROUP: Western medicine treatment plan. All participants will continue to receive conventional drug treatment. The selection of outcomes will be evaluated by Mini Mental State Examination Scale (MMSE) at week 12. The scale will be conducted by two well-trained reviewers who will conduct joint MMSE inspections on participants. The test time will be selected 3 days before treatment and once 4 weeks after treatment. After the MMSE test, the two raters scored independently, and the average of the two was used as the final score. DISCUSSION: This trial may provide evidence regarding the clinical effectiveness, safety, and cost-effectiveness of acupuncture for patients with PSCI. TRIAL REGISTRATION: ClinicalTrials.gov ChiCTR2000029926. Registered on 17 February 2020 http://www.chictr.org.cn/showproj.aspx?proj=49356.
引用
- Liu R, Yu X, Wang J, et al. Evaluation of the efficacy and safety of the use of acupuncture for the adjuvant treatment of patients with post-stroke cognitive impairment: protocol for a randomized controlled trial. Trials. 2020. PMID: 32859250. doi:10.1186/s13063-020-04656-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。